Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 32, pseudogene (RN7SL32P)

Target
RN7SL32P
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

RNA, 7SL, cytoplasmic 32, pseudogene (RN7SL32P) is classified as a **pseudogene** and does not encode a functional protein or receptor[1][4]. Pseudogenes like RN7SL32P are often remnants of genes, in this case related to the signal recognition particle RNA family (7SL RNA), but typically lack known biological function and are not therapeutic targets. Some pseudogenes can regulate other genes by acting as *competing endogenous RNAs* or *miRNA sponges*, but this has not been specifically demonstrated for RN7SL32P[6]. According to the HUGO Gene Nomenclature Committee, the entry for RN7SL32P has been withdrawn, further indicating it is not considered a functional or clinically relevant gene[4]. There is **no evidence this pseudogene is a therapeutic target, is involved in disease, interacts with drugs, or is used as a biomarker**. **Key notes:** - The naming and pseudogene status are accurate, but it is not a biologically active or druggable target[1][4]. - No established role in disease or human physiology. - No interacting drugs, mechanisms, or biomarker roles. - Some sources highlight the regulatory and epigenetic potential of pseudogenes in general, but **no evidence** specific to RN7SL32P[6].

Other names
RN7SL32P
02

Biological functions

Other (Potential miRNA sponge activity—general to some pseudogene transcripts, not specifically established for RN7SL32P)
03

Disease associations

Other (No known direct disease association; some pseudogenes implicated in gene regulation but not specifically established for RN7SL32P)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 32, pseudogene (RN7SL32P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 32, pseudogene (RN7SL32P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call